BM0026
BMS-986034
≥98% (HPLC)
别名:
(R)-5-Chloro-4-(1-(5-chloropyrimidin-2-yl)piperidin-4-yloxy)-1-(5-(3-hydroxy-2-oxopyrrolidin-1-yl)-6-methylpyridin-2-yl)pyridin-2(1H)-one, 5-Chloro-4-[[1-(5-chloro-2-pyrimidinyl)-4-piperidinyl]oxy]-5′-[(3R)-3-hydroxy-2-oxo-1-pyrrolidinyl]-6′-methyl-[1(2H),2′-bipyridin]-2-one
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C24H24Cl2N6O4
化学文摘社编号:
分子量:
531.39
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 5 mg/mL, clear (warmed)
storage temp.
room temp
SMILES string
ClC(C(OC1CCN(C2=NC=C(Cl)C=N2)CC1)=C3)=CN(C4=NC(C)=C(N5C([C@H](O)CC5)=O)C=C4)C3=O
Biochem/physiol Actions
BMS-986034 is a GPR119 agonist.
Features and Benefits
BMS-986034 is available through a partnership with Bristol-Myers Squibb (BMS). To learn more and view other BMS compounds, visit sigma.com/BMS.
Legal Information
Sold for research purposes only under agreement from BMS.
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| BM0026-25MG | 04061832269504 |
| BM0026-5MG | 04061832269511 |